CADL
Candel TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
CADL vs peer average
53/100
CADL vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
PRME is the first available peer comparator.
Similar-sized development-stage biotechnology candidate, but its modality and pipeline risks differ; useful only as a broad financing-risk comparator.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CADL
Candel Therapeutics
PRME
Prime Medicine
Grade
D
D
Momentum
13
95
Value
41
41
Sentiment
65
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs PRME
CADL / PRME
Grade Position
In line
CADL vs. peer average (D vs. D)
53/100
Momentum
13
PRMEValue
41
CADLSentiment
65
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CADL
PRME is the first peer returned for this comparison set.